Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2000; 36:423-426
© 2000 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Lemos, J. A.
Right arrow Articles by Ridker, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Lemos, J. A.
Right arrow Articles by Ridker, P. M.

Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk

James A. de Lemos, MD* {dagger}, Charles H. Hennekens, MD|| and Paul M. Ridker, MD, FACC* || §

* Center for Cardiovascular Disease Prevention, Brigham and Women’s Hospital, Boston, Massachusetts, USA
{dagger} the Leducq Center for Molecular and Genetic Epidemology of Cardiovascular Disease; Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston, Massachusetts, USA
§ Division of Preventive Medicine, Brigham and Women’s Hospital, Boston, Massachusetts, USA
|| Department of Medicine, University of Miami School of Medicine, Miami, Florida, USA



View larger version (11K):

[in a new window]
 
Figure 1 Relative risk (95% confidence interval) for first MI associated with a baseline sVCAM-1 concentration ≥ the 75th percentile, according to year of follow-up.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement